TIBSOVO

Опис товару

About TIBSOVO

TIBSOVO is a prescription medicine used to treat adults with a type of cancer called acute myeloid leukemia (AML) with a specific genetic mutation called an isocitrate dehydrogenase-1 (IDH1) mutation.

Key Benefits & Uses

• Treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-1 (IDH1) mutation.
• Treatment of adult patients with newly diagnosed AML with an IDH1 mutation.

Active Ingredient & Action

TIBSOVO contains the active ingredient ivosidenib, a potent and selective inhibitor of the IDH1 enzyme. Ivosidenib works by blocking the IDH1 enzyme, which is mutated in AML cells, leading to the accumulation of a toxic metabolite that ultimately causes cell death.

Important Notes

It is essential to consult a healthcare professional before taking TIBSOVO. The safety and efficacy of TIBSOVO in patients with severe renal impairment, severe hepatic impairment, or those with a history of cardiac disease have not been established. TIBSOVO can cause serious side effects, including differentiation syndrome, QT interval prolongation, and torsades de pointes. Patients should be closely monitored for these and other potential side effects.